Local Officials Grapple With How to Spend Billions in Opioid Settlement Dollars
More than $50 billion in opioid settlement dollars from drugmakers, distributors and pharmacies are starting to flow to state and local governments.
Read MorePrescription drugs
Local Officials Grapple With How to Spend Billions in Opioid Settlement Dollars Transcript
‘Local Officials Grapple With How to Spend Opioid Settlement Dollars’ Transcript November 17, 2022 Note: This transcript has been created with a combination of machine ears and human eyes. There may be small differences between this document and the audio version, which is one of many reasons we encourage you to listen to the episode! Listen…
Read MoreMedicare’s Prescription Drug Plan Makeover Transcript
‘Medicare’s Prescription Drug Plan Makeover’ Transcript October 27, 2022 Note: This transcript has been created with a combination of machine ears and human eyes. There may be small differences between this document and the audio version, which is one of many reasons we encourage you to listen to the episode! Listen in Apple Podcasts Listen on Spotify…
Read More
Medicare’s Prescription Drug Plan Makeover
An overhaul of Medicare’s prescription drug benefit will lower costs for seniors while changing incentives for insurers and drugmakers.
Read More
The Race to Prepare for Medicare’s New Drug Pricing Powers
Congress gave Medicare historic new powers to lower drug prices, but lawsuits, loopholes and opposition from the drug industry could undermine them.
Read More
Dems’ New Drug Pricing Deal: What You Need to Know
Stacie Duestzina shares key takeaways from the drug pricing provisions of the new Inflation Reduction Act.
Read More
Good Intentions Gone Awry
Why has a little-known program designed to help hospitals and clinics that serve low-income people become so controversial?
Read More
America’s Chronic Drug Shortage Problem
How one hospital is scrambling to deal with a shortage of a critical drug, and the changes needed to fix chronic supply chain issues.
Read More
Digging Into the Growth in 340B Contract Pharmacies
Paula Chatterjee shares new research on the whether a popular discount drug program is reaching the patients it was designed to support.
Read More
3 Studies That Show the Promise of Telemedicine Data
Ateev Mehrotra explains why a trio of studies on overprescribing antiobiotics has him excited about telemedicine data.
Read More